======= AGPAT3 ======= == Gene Information == * **Official Symbol**: AGPAT3 * **Official Name**: 1-acylglycerol-3-phosphate O-acyltransferase 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56894|56894]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NRZ7|Q9NRZ7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AGPAT3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AGPAT3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614794|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone. Acts on LPA containing saturated or unsaturated fatty acids C16:0-C20:4 at the sn-1 position using C18:1, C20:4 or C18:2-CoA as the acyl donor. Also acts on lysophosphatidylcholine, lysophosphatidylinositol and lysophosphatidylserine using C18:1 or C20:4-CoA (PubMed:21173190). Has a preference for arachidonoyl-CoA as a donor. Has also a modest lysophosphatidylinositol acyltransferase (LPIAT) activity, converts lysophosphatidylinositol (LPI) into phosphatidylinositol (By similarity). {ECO:0000250|UniProtKB:Q9D517, ECO:0000269|PubMed:21173190}. |Acyltransferase| |CDP-diacylglycerol biosynthetic process| |CDP-diacylglycerol metabolic process| |1-acylglycerol-3-phosphate O-acyltransferase activity| |transferase activity, transferring acyl groups| |phosphatidic acid biosynthetic process| |phosphatidic acid metabolic process| |pyrimidine nucleotide biosynthetic process| |pyrimidine-containing compound biosynthetic process| |pyrimidine nucleotide metabolic process| |pyrimidine-containing compound metabolic process| |nuclear envelope| |glycerophospholipid biosynthetic process| |glycerolipid biosynthetic process| |nucleotide biosynthetic process| |phospholipid biosynthetic process| |nucleoside phosphate biosynthetic process| |glycerophospholipid metabolic process| |phospholipid metabolic process| |glycerolipid metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |lipid biosynthetic process| |Golgi membrane| |organophosphate metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |endoplasmic reticulum| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |lipid metabolic process| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|1.81| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|1.97| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6953 * **Expression level (log2 read counts)**: 4.7 {{:chemogenomics:nalm6 dist.png?nolink |}}